tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
United Therapeutics Corp. (UTHR) Q2 Earnings Cheat Sheet
PremiumPre-EarningsUnited Therapeutics Corp. (UTHR) Q2 Earnings Cheat Sheet
2d ago
Positive Outlook for United Therapeutics Driven by Tyvaso Growth and IPF Potential
Premium
Ratings
Positive Outlook for United Therapeutics Driven by Tyvaso Growth and IPF Potential
6d ago
Optimistic Buy Rating for United Therapeutics Amid Promising Tyvaso Developments in IPF Treatment
Premium
Ratings
Optimistic Buy Rating for United Therapeutics Amid Promising Tyvaso Developments in IPF Treatment
15d ago
United Therapeutics’ Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis: Key Insights for Investors
PremiumCompany AnnouncementsUnited Therapeutics’ Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis: Key Insights for Investors
21d ago
United Therapeutics price target lowered to $330 from $350 at JPMorgan
Premium
The Fly
United Therapeutics price target lowered to $330 from $350 at JPMorgan
22d ago
United Therapeutics’ Inhaled Treprostinil Study: A Potential Game-Changer for IPF Treatment
Premium
Company Announcements
United Therapeutics’ Inhaled Treprostinil Study: A Potential Game-Changer for IPF Treatment
30d ago
United Therapeutics’ Ralinepag Study: A Potential Game-Changer in PAH Treatment
PremiumCompany AnnouncementsUnited Therapeutics’ Ralinepag Study: A Potential Game-Changer in PAH Treatment
1M ago
United Therapeutics: Pioneering Organ Manufacturing and Strategic Growth with miroliverELAP
Premium
Ratings
United Therapeutics: Pioneering Organ Manufacturing and Strategic Growth with miroliverELAP
1M ago
United Therapeutics’ Ralinepag Study: A Potential Game-Changer for PAH Treatment
Premium
Company Announcements
United Therapeutics’ Ralinepag Study: A Potential Game-Changer for PAH Treatment
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100